Metabolic inactivation of 2-oxiranylmethyl 2-ethyl-2,5-dimethylhexanoate (C10GE) in skin, lung and liver of human, rat and mouse

被引:5
作者
Boogaard, PJ [1 ]
van Elburg, PA [1 ]
de Kloe, KP [1 ]
Watson, WP [1 ]
van Sittert, NJ [1 ]
机构
[1] Shell Int Chem BV, Shell Res & Technol Ctr, Dept Mol Toxicol, NL-1030 BN Amsterdam, Netherlands
关键词
D O I
10.1080/004982599238065
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The inactivation of 2-oxiranylmethyl 2-ethyl-2,5-dimethylhexanoate (C(10)GE), one of the most abundant isomers of the epoxy-resin Cardura(R) E-10 glycidyl ester, was studied in subcellular fractions of human, C3H mouse and F344 rat liver, lung and skin. 2. C(10)GE is chemically very stable and resistant to aqueous hydrolysis, but it was rapidly metabolized in both cytosolic and microsomal fractions of all organs by epoxide hydrolase (EH)-catalysed hydrolysis of the epoxide moiety as well as carboxylesterase (CE)-catalysed hydrolysis of the ester bond. In cytosol the epoxide group was also effciently conjugated with glutathione, catalysed by glutathione S-transferase (GST), but this conjugation was much less important than hydrolysis in human as well as rodent samples. Although CE-catalysed hydrolysis of C(10)GE would theoretically give rise to the formation of glycidol, a directly acting mutagen, it is highly unlikely that any significant level of glycidol would occur in vivo since reported rates of inactivation of glycidol exceed the total rate of hydrolysis of C(10)GE. 3. The overall rates of inactivation in vitro decreased in the following order: mouse, rat > human. Scaling of the data in vitro to clearances in vivo suggests that the detoxifying capacity in the rodents is similar and about an order of magnitude greater than in human. Nevertheless, the rate of inactivation is 2-3 orders of magnitude greater than for simple epoxides such as butadiene monoxide and about one order of magnitude higher than for the diglycidyl ether of bisphenol A (BADGE). 4. The transdermal penetration and metabolism of [C-14]-C(10)GE was studied in fresh full-thickness mouse, and dermatomized human and rat skin. Of the total radioactivity applied on the skin, only 0.24+/-0.06 (SD), 1.8 +/- 0.2 and 6.8 +/- 0.6 % penetrated through human, mouse and rat skin respectively. The corresponding apparent skin permeability constants were 0.81, 6.42 and 26.4 x 10(-6) cm/h. 5. During transdermal penetration, [C-14]-C(10)GE was extensively hydrolysed to the corresponding diol and the free acid. Only 0.01, 0.11 and 0.21 % of the applied dose was absorbed unchanged through the human, mouse and rat skin respectively.
引用
收藏
页码:987 / 1006
页数:20
相关论文
共 26 条
[1]   A COMPARATIVE-STUDY OF THE RATES OF INVITRO PERCUTANEOUS-ABSORPTION OF 8 CHEMICALS USING RAT AND HUMAN SKIN [J].
BARBER, ED ;
TEETSEL, NM ;
KOLBERG, KF ;
GUEST, D .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1992, 19 (04) :493-497
[2]   HYDROLYSIS OF BISPHENOL-A DIGLYCIDYLETHER BY EPOXIDE HYDROLASES IN CYTOSOLIC AND MICROSOMAL FRACTIONS OF MOUSE-LIVER AND SKIN - INHIBITION BY BIS-EPOXYCYCLOPENTYLETHER AND THE EFFECTS UPON THE COVALENT BINDING TO MOUSE SKIN DNA [J].
BENTLEY, P ;
BIERI, F ;
KUSTER, H ;
MUAKKASSAHKELLY, S ;
SAGELSDORFF, P ;
STAUBLI, W ;
WAECHTER, F .
CARCINOGENESIS, 1989, 10 (02) :321-327
[3]   Hepatic and pulmonary glutathione conjugation of 1,2:3,4-diepoxybutane in human, rat, and mouse in vitro [J].
Boogaard, PJ ;
Sumner, SCJ ;
Turner, MJ ;
Bond, JA .
TOXICOLOGY, 1996, 113 (1-3) :297-299
[4]   The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro [J].
Boogaard, PJ ;
Bond, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 141 (02) :617-627
[5]   Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro [J].
Boogaard, PJ ;
Sumner, SCJ ;
Bond, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 136 (02) :307-316
[6]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .1. COMPARISON WITH INVIVO RESULTS [J].
BRONAUGH, RL ;
STEWART, RF ;
CONGDON, ER ;
GILES, AL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 62 (03) :474-480
[7]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .2. ANIMAL-MODELS FOR HUMAN-SKIN [J].
BRONAUGH, RL ;
STEWART, RF ;
CONGDON, ER .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 62 (03) :481-488
[8]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .4. THE FLOW-THROUGH DIFFUSION CELL [J].
BRONAUGH, RL ;
STEWART, RF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (01) :64-67
[9]   FATE OF FLUAZIFOP BUTYL IN RAT AND HUMAN SKIN INVITRO [J].
CLARK, NWE ;
SCOTT, RC ;
BLAIN, PG ;
WILLIAMS, FM .
ARCHIVES OF TOXICOLOGY, 1993, 67 (01) :44-48
[10]   METABOLISM OF THE EPOXY-RESIN COMPONENT 2,2-BIS[4-(2,3-EPOXYPROPOXY)PHENYL]PROPANE, THE DIGLYCIDYL ETHER OF BISPHENOL-A (DGEBPA) IN THE MOUSE .2. IDENTIFICATION OF METABOLITES IN URINE AND FECES FOLLOWING A SINGLE ORAL DOSE OF DGEBPA-C-14 [J].
CLIMIE, IJG ;
HUTSON, DH ;
STOYDIN, G .
XENOBIOTICA, 1981, 11 (06) :401-424